Aura, a leader in personalized healthcare, has launched a groundbreaking at-home health check in New York. In just one hour, nurses conduct extensive blood work, imaging, cognitive assessments, and more,…
MATTER, a leading healthcare incubator and innovation hub, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) as the Digital Health Hub for the BARDA Accelerator Network.…
Massive Bio, a global leader in AI-driven cancer clinical trial enrollment, has launched Patient Connect, a new free portal designed to streamline cancer patients’ access to clinical trials worldwide. Patient…
Cellworks Group Inc., a leader in personalized therapy decision support and precision drug development, has announced promising results from a study using its computational biosimulation to predict immunotherapy (IO) responses…
SamanTree Medical, a pioneer in surgical imaging technology, has announced that its Histolog® Scanner has received FDA 510(k) clearance. This groundbreaking Swiss device offers real-time, high-resolution imaging of fresh tissue…
Massive Bio, an AI-powered clinical trial matching platform, and Foundation Medicine have announced a strategic partnership to expand patient access to advanced clinical trials. The collaboration combines Massive Bio’s patient-matching…
Medidata, a Dassault Systèmes brand and leader in clinical trial solutions for the life sciences industry, has announced a four-year extension of its partnership with the European Organisation for Research…
HDS has launched Script Scan, a new addition to its Spotlight platform. This is the company’s first product specifically designed for pharmacies. Script Scan addresses the current challenges faced by…
Catalyst OrthoScience Inc., a private medical technology company specializing in shoulder arthroplasty—the fastest growing segment in the orthopedics market—has surpassed 10,000 total shoulder arthroplasty (TSA) procedures. The milestone coincides with…
Doctors are increasingly using contrast-enhanced ultrasound (CEUS) for imaging kidney masses in patients with polycystic kidney disease, often bypassing CT scans altogether due to CEUS’s effectiveness. “They go right to…
Bristol Myers Squibb (NYSE: BMY) has announced new long-term follow-up data from the EXPLORER-LTE cohort of the MAVA-Long-Term Extension (LTE) study. This data evaluates the efficacy and safety of CAMZYOS®…
Elixir Medical, a developer of innovative cardiovascular technologies, announced that the INFINITY-SWEDEHEART Randomized Controlled Trial (RCT) has met its primary endpoint. The trial compared the novel DynamX® Coronary Bioadaptor System…